Nathan DM. Realising the long-term promise of insulin therapy: the DCCT/EDIC study. Diabetologia. 2021;64(5):1049–58.

Article  PubMed  CAS  Google Scholar 

Evans M, Khunti K, Mamdani M, et al. Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes. 2013;11:90.

Article  PubMed  PubMed Central  Google Scholar 

Galindo RJ, Aleppo G. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract. 2020;170: 108502.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254–63.

Article  PubMed  Google Scholar 

Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, et al. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia. 2018;61(3):539–50.

Article  PubMed  CAS  Google Scholar 

Roze S, Isitt JJ, Smith-Palmer J, et al. Long-term cost-effectiveness the Dexcom G6 real-time continuous glucose monitoring system compared with self-monitoring of blood glucose in people with type 1 diabetes in France. Diabetes Ther. 2021;12(1):235–46.

Article  PubMed  Google Scholar 

García-Lorenzo B, Rivero-Santana A, Vallejo-Torres L, et al. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain. J Eval Clin Pract. 2018;24(4):772–81.

Article  PubMed  Google Scholar 

Bidonde J, Fagerlund BC, Frønsdal KB, et al. FreeStyle libre flash glucose self-monitoring system: a single-technology assessment [Internet]. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017. Report from the Norwegian Institute of Public Health No. 2017-07.

Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev. 2009;25(8):705–16.

Article  PubMed  Google Scholar 

Myung JE, Tanaka Y, Choi H, et al. Coverage with Evidence Development Programs for Medical Technologies in Asia-Pacific Regions: A Case Study of Japan and South Korea. JMA J. 2021;4(4):311–20.

PubMed  PubMed Central  Google Scholar 

Matsuda S. Health policy in Japan - current situation and future challenges. JMA J. 2019;2(1):1–10.

Article  PubMed  PubMed Central  Google Scholar 

ISCHIA Study Group. Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: a randomized, crossover trial. Diabetes Res Clin Pract 2023;195:110147

Suzuki S, Tone A, Murata T, et al. Protocol for a randomized, crossover trial to decrease time in hypoglycemia by combined intervention of the usage of intermittent-scanning continuous glucose monitoring device and the structured education regarding its usage: effect of intermittent-scanning continuous glucose monitoring to glycemic control including hypoglycemia and quality of life of patients with type 1 diabetes mellitus study (ISCHIA study). Tokai J Exp Clin Med. 2021;46(2):59–68.

PubMed  Google Scholar 

Gubitosi-Klug RA, Braffett BH, White NH, et al. Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study. Diabetes Care. 2017;40(8):1010–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2017;60(1):3–6.

Li J, Ma X, Tobore I, Liu Y, et al. A novel CGM metric-gradient and combining mean sensor glucose enable to improve the prediction of nocturnal hypoglycemic events in patients with diabetes. J Diabetes Res. 2020;2020:8830774.

Article  PubMed  PubMed Central  Google Scholar 

Kovatchev BP, Cox DJ, Gonder-Frederick LA, et al. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998;21(11):1870–5.

Article  PubMed  CAS  Google Scholar 

Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6.

Snoek FJ, Kersch NY, Eldrup E, et al. Monitoring of individual needs in diabetes (MIND): baseline data from the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2011;34(3):601–3.

Article  PubMed  PubMed Central  Google Scholar 

Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617–21.

Article  PubMed  CAS  Google Scholar 

Everest L, Chen BE, Hay AE, Cheung MC, Chan KKW. Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group. BMC Med Res Methodol. 2023;23(1):179.

Article  PubMed  PubMed Central  Google Scholar 

Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–37.

Article  PubMed  Google Scholar 

Kondo Y, Tachi T, Sakakibara T, et al. Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy. J Pharm Health Care Sci. 2022;8(1):15.

Article  PubMed  PubMed Central  Google Scholar 

Tsuji S, Ishikawa T, Morii Y, et al. Cost-effectiveness of a continuous glucose monitoring mobile app for patients with type 2 diabetes mellitus: analysis simulation. J Med Internet Res. 2020;22(9):e16053.

Article  PubMed  PubMed Central  Google Scholar 

Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795–800.

Article  PubMed  PubMed Central  Google Scholar 

Bilir SP, Hellmund R, Wehler B, et al. Cost-effectiveness analysis of a flash glucose monitoring system for patients with type 1 diabetes receiving intensive insulin treatment in Sweden. Eur Endocrinol. 2018;14(2):73–9.

PubMed  PubMed Central  Google Scholar 

Gil-Ibáñez MT, Aispuru GR. Cost-effectiveness analysis of glycaemic control of a glucose monitoring system (FreeStyle Libre®) for patients with type 1 diabetes in primary health care of Burgos. Enferm Clin (Engl Ed). 2020;30(2):82–8.

Article  PubMed  Google Scholar 

Oyagüez I, Merino-Torres JF, Brito M, et al. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care. 2020;8(1):e001330.

Article  PubMed  PubMed Central  Google Scholar 

Bilir SP, Li H, Wehler EA, et al. Cost effectiveness analysis of a flash glucose monitoring system for type 1 diabetes (T1DM) patients receiving intensive insulin treatment in Europe and Australia. Value Health. 2016;19(7):A697–8.

Article  Google Scholar 

Pollock RF, Tikkanen CK. A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark. J Med Econ. 2017;20(3):213–20.

Article  PubMed  CAS  Google Scholar 

Brod M, Christensen T, Bushnell DM. The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. J Med Econ. 2012;15(5):869–77.

Article  PubMed  Google Scholar 

Pedersen-Bjergaard U, Kristensen PL, Nørgaard K, et al. Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia. Curr Med Res Opin. 2016;32(10):1719–25.

Article  PubMed  CAS  Google Scholar 

Jiao Y, Lin R, Hua X, Churilov L, Gaca MJ, James S, Clarke PM, O’Neal D, Ekinci EI. A systematic review: cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022;5(6):e369.

Article  PubMed  PubMed Central  Google Scholar 

Mustonen J, Rautiainen P, Lamidi ML, Lavikainen P, Martikainen J, Laatikainen T. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients. Acta Diabetol. 2023;60(7):891–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bader C, Cossin S, Maillard A, Bénard A. A new approach for sample size calculation in cost-effectiveness studies based on value of information. BMC Med Res Methodol. 2018;18(1):113.